H.R. 8005
Stop Pills That Kill Act
Sponsor: Gabe Evans · 0 cosponsors
Official summary
Written by the Congressional Research Service.
Stop Pills That Kill Act
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.
Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).
The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
Text of the bill
Where this section came from
Not in the first version (Introduced in House, Mar 19).
-
Sep 15, 2026 · Engrossed in House Marked up by House Committee on Energy and Commerce, Jul 20 Marked up by House Committee on Energy and Commerce, Jul 21 Committee members' individual votes aren't in our records.
What is a markup?
A markup is a committee meeting where members go through a bill and vote on changes before sending it to the full chamber.
(a) Definition. In this Act, the term counterfeit pill containing an illicit synthetic substance means a substance in pill or tablet form that—
(1) is a counterfeit substance, as defined in section 102(7) of the Controlled Substances Act (21 U.S.C. 802(7)); and
(2) contains fentanyl, an analogue of fentanyl, a fentanyl-related substance, methamphetamine, an illicit depressant or stimulant substance, an illicit narcotic, or an illicit synthetic opioid.
(b) Prohibited acts. Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting , fentanyl, an analogue of fentanyl, or a fentanyl-related substance after methamphetamine.
(c) Comprehensive plan
(1) In general. Not later than 180 days after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration shall establish and implement an operation and response plan to address counterfeit pills containing an illicit synthetic substance.
(2) Contents. The plan required under paragraph (1) shall include—
(A) strategies to enable and empower Federal law enforcement efforts to investigate and seize counterfeit pills containing an illicit synthetic substance;
(B) specific ways that education and prevention efforts to stop the use of counterfeit pills containing an illicit synthetic substance will be increased, including—
(i) how ongoing efforts, such as Operation Engage, are effective in increasing education and prevention; and
(ii) how such ongoing efforts are tailored to youth and teen access; and
(C) an audit of current campaigns on counterfeit pills containing an illicit synthetic substance, including a review of data and other available information on how the campaigns can be tailored, adjusted, or improved to better address the flow of such counterfeit pills.
(3) Report to Congress
(A) Report. Not later than 1 year after the date of enactment of this Act, and every year thereafter through fiscal year 2031, the Attorney General, in consultation with the Administrator of the Drug Enforcement Administration and the Director of the Office of National Drug Control Policy, shall submit to Congress a report containing information regarding the collection of counterfeit pills containing an illicit synthetic substance and prosecutions undertaken in connection with such counterfeit pills.
(B) Contents. The report required under subparagraph (A) shall include the following:
(i) Data on the aggregate number of counterfeit pills containing an illicit synthetic substance that have been seized and collected by Federal law enforcement agencies.
(ii) A description of pharmaceutical markings used for counterfeit pills containing an illicit synthetic substance, including how the markings compare to required labeling for products approved by the Food and Drug Administration.
(iii) A breakdown of which illicit substances are present in counterfeit pills containing an illicit synthetic substance.
(iv) Data outlining the geographic origin and points of seizure of counterfeit pills containing an illicit synthetic substance.
(v) Data on the charges filed pursuant to paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) in relation to counterfeit pills containing an illicit synthetic substance, unless disclosure of the data would—
(I) require unsealing an indictment; or
(II) undermine investigations and charges brought by the Department of Justice.
(vi) Data on the convictions and sentences against those who are found guilty under paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) as it pertains to counterfeit pills containing an illicit synthetic substance.
(vii) Any prevention measures that the Department of Justice, the Drug Enforcement Administration, or the Office of National Drug Control Policy are undertaking to limit and reduce the spread of counterfeit pills containing an illicit synthetic substance, including ongoing public awareness campaigns.